These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9097987)

  • 21. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of class II-associated invariant chain peptide on leukemic blasts of patients promotes activation of autologous leukemia-reactive CD4+ T cells.
    van Luijn MM; van den Ancker W; Chamuleau ME; Zevenbergen A; Westers TM; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
    Cancer Res; 2011 Apr; 71(7):2507-17. PubMed ID: 21310823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in the frequencies of HLA-class I and II alleles between German patients with renal cell carcinoma and healthy controls.
    Goebel S; Kehlen A; Bluemke K; Altermann W; Schlaf G; Fischer K; Fornara P; Wullich B; Wach S; Taubert H
    Cancer Immunol Immunother; 2017 May; 66(5):565-571. PubMed ID: 28184970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas.
    Dengjel J; Nastke MD; Gouttefangeas C; Gitsioudis G; Schoor O; Altenberend F; Müller M; Krämer B; Missiou A; Sauter M; Hennenlotter J; Wernet D; Stenzl A; Rammensee HG; Klingel K; Stevanović S
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4163-70. PubMed ID: 16857787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma.
    Kowalczyk D; Skorupski W; Kwias Z; Nowak J
    Br J Urol; 1997 Oct; 80(4):543-7. PubMed ID: 9352689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of T-cell immune response in renal cell carcinoma: polarization to type 1-like differentiation pattern, clonal T-cell expansion and tumor-specific cytotoxicity.
    Angevin E; Kremer F; Gaudin C; Hercend T; Triebel F
    Int J Cancer; 1997 Jul; 72(3):431-40. PubMed ID: 9247286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vectorial function of major histocompatibility complex class II in a human intestinal cell line.
    Lopes LM; Hughson E; Anstee Q; O'Neil D; Katz DR; Chain BM
    Immunology; 1999 Sep; 98(1):16-26. PubMed ID: 10469229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.
    Mulders P; Tso CL; Gitlitz B; Kaboo R; Hinkel A; Frand S; Kiertscher S; Roth MD; deKernion J; Figlin R; Belldegrun A
    Clin Cancer Res; 1999 Feb; 5(2):445-54. PubMed ID: 10037196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal recruitment and activation of dendritic cells within renal cell carcinoma.
    Troy AJ; Summers KL; Davidson PJ; Atkinson CH; Hart DN
    Clin Cancer Res; 1998 Mar; 4(3):585-93. PubMed ID: 9533525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
    Glew SS; Duggan-Keen M; Cabrera T; Stern PL
    Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
    Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor dependent, interferon-gamma induced HLA-DR expression on human neutrophils in vivo.
    Reinisch W; Lichtenberger C; Steger G; Tillinger W; Scheiner O; Gangl A; Maurer D; Willheim M
    Clin Exp Immunol; 2003 Sep; 133(3):476-84. PubMed ID: 12930377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invariant chain-MHC class II complexes: always odd and never invariant.
    Cresswell P; Roche PA
    Immunol Cell Biol; 2014 Jul; 92(6):471-2. PubMed ID: 24777311
    [No Abstract]   [Full Text] [Related]  

  • 34. [Expression of major histocompatibility complex antigens and adhesion molecules on renal cell carcinoma cells, and effect of interferon-alpha and/or cimetidine on the expression].
    Wu XX; Mizutani Y; Kakehi Y; Nakamura E; Mitsumori K; Takahashi T; Terachi T; Okada Y; Yoshida O
    Hinyokika Kiyo; 1998 Sep; 44(9):621-6. PubMed ID: 9805665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes.
    Thompson JA; Srivastava MK; Bosch JJ; Clements VK; Ksander BR; Ostrand-Rosenberg S
    Cancer Immunol Immunother; 2008 Mar; 57(3):389-98. PubMed ID: 17724589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interferon-induced protection of renal cell cancer cell lines to lymphokine-activated killer (LAK) cells and effect of acid treatment on their susceptibility. Its relevance to expression of major histocompatibility complex class I antigens on tumor cells].
    Tomita Y; Kimura M; Nishiyama T; Sato S
    Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):762-8. PubMed ID: 1908533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced susceptibility of adriamycin-treated human renal cell carcinoma cells to lysis by peripheral blood lymphocytes and tumor infiltrating lymphocytes.
    Wu XX; Zeng Y; Jin XH; Kakehi Y
    Oncol Rep; 2007 Aug; 18(2):353-9. PubMed ID: 17611656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
    Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
    Shaw AR; Chan JK; Reid S; Seehafer J
    J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue.
    Sáenz-López P; Gouttefangeas C; Hennenlotter J; Concha A; Maleno I; Ruiz-Cabello F; Cózar JM; Tallada M; Stenzl A; Rammensee HG; Garrido F; Cabrera T
    Tissue Antigens; 2010 Feb; 75(2):110-8. PubMed ID: 19912575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.